Le Lézard
Classified in: Health, Covid-19 virus
Subjects: CHI, CFG, DEI

Prime Minister to hold virtual Cabinet retreat


OTTAWA, ON, Jan. 21, 2022 /CNW/ -The Prime Minister, Justin Trudeau, today announced that he will hold a virtual Cabinet retreat from January 24 to 26.

The Cabinet retreat will focus on the Government of Canada's efforts to address the economic impacts of the COVID-19 pandemic and work toward a strong recovery that benefits all Canadians. This includes creating jobs, investing in a green economy, and supporting Canadians and businesses as we get through the Omicron wave. It also includes delivering on $10-a-day child care, getting the job done on the vaccine rollout, tackling the climate crisis, and creating affordable housing. Ministers will discuss these and other priorities as we work to grow the middle class and those who are working hard to join it.

The Government of Canada will continue to work with the provinces, territories, municipalities, Indigenous Peoples, global partners, businesses, and other stakeholders on the outlined priorities and other important issues. As Parliament resumes at the end of the month, the government will also work with all parliamentarians to deliver positive results, support Canadians through COVID-19, and continue to find real solutions to challenges at home and abroad.

Quote
"With the start of a new year, this Cabinet retreat will be an important opportunity to discuss the government's focus on building a more resilient economy, making life more affordable, and creating jobs and growing the middle class. Together, we will continue to build a safer, more prosperous, and fairer Canada that works for everyone."
? The Rt. Hon. Justin Trudeau, Prime Minister of Canada

Associated Link

This document is also available at https://pm.gc.ca

SOURCE Prime Minister's Office


These press releases may also interest you

at 01:20
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

18 avr 2024
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: